Endo 2 SLO Practice (online) Page 1 of 7

Size: px
Start display at page:

Download "Endo 2 SLO Practice (online) Page 1 of 7"

Transcription

1 Endo 2 SLO Practice (online) Page 1 of 7 1. A long- acting insulin, like Lantus is for? A. When the next meal is within minutes of the injection B. Over night use or for ½ of the day often combined with another form C. Taking with meals, often combined with longer acting form. D. Covering the whole day (24 hrs.), providing "basal" insulin and may be combined with another form 2. A major consequence of insulin binding to its cell surface receptors on muscle and fat cells is the translocation of the GLUT- 4 transporter from the cytosol to the cell surface, allowing? to flow into the cell. A. Cholesterol B. Glycogen C. Calcium D. Glucose E. Fatty acids 3. A number of drugs increase the risk of severe hypoglycemia when given with sulfonylureas. Which of the following should be avoided or used with great caution by patients taking a sulfonylurea? A. NSAIDs and salicylates in large doses B. Sulfonamides including thiazide diuretics C. Coumarins (e.g., warfarin) D. Beta blockers E. All the above 4. A Rapid- acting insulin, like Humalog is for A. When the next meal is within minutes of the injection B. Covering the whole day (24 hrs.) and may be combined with another form C. Taking with meals, often combined with longer acting form. D. Over night use or for ½ of the day often combined with another form 5. A short- acting insulin, like Humulin is for? A. Taking with meals, often combined with longer acting form. B. Over night use or for ½ of the day often combined with another form C. Covering the whole day (24 hrs.) and may be combined with another form D. When the next meal is within minutes of the injection 6. A type of diabetes that has mixed DMT1 & DMT2 characteristics is associated with A. Diabetes mellitus type 1 B. Diabetes mellitus type 2 C. Cystic fibrosis D. Diabetes insipidus E. Gestational diabetes 7. Acarbose (Precose) inhibits a glucosidase, which means it acts to reduce blood glucose by? A. Blocking hepatic gluconeogenesis B. Preventing the digestion and absorption of carbohydrates C. Stimulating the pancreas to release more insulin D. Mimicking incretins E. Preventing the breakdown of incretins

2 Endo 2 SLO Practice (online) Page 2 of 7 8. Acarbose (Precose) is a(n)? antihyperglycemic drug used as an adjunct to diet and exercise to treat A. Parenteral /DMT1 B. Oral /DMT 1 and DMT 2 C. Parenteral/Hypoglycemia D. Parenteral /DMT1 and some cases of DMT2 E. Oral /Diabetes insipidus 9. Alpha glucosidase inhibitors like? are associated with gas. A. Glucagon B. Acarbose C. Metformin D. Insulin E. Liraglutide 10. An Intermediate- acting insulin, like NPH is for? A. Over night use or for ½ of the day often combined with another form B. Taking with meals, often combined with longer acting form. C. When the next meal is within minutes of the injection D. Covering the whole day (24 hrs.) & may be combined with another form 11. Bromocriptine given in very low doses first thing in the morning is indicated to help provide glycemic control in DMT2 patients along with diet and exercise. This product is called? A. Cycloset B. Parlodel C. Navane D. Stalevo E. L- Dopa 12. Chlorpropamide (Diabinese) is a 1 st generation sulfonylurea, which makes it a secretagogue. What does secretagogue mean? A. It stimulates the pancreas to secrete glucagon B. It causes muscle and fat cells to secrete insulin C. It stimulates the pancreas to secrete insulin D. It prevents the pancreas from releasing insulin E. It inhibits secreted insulin from binding to its receptor 13. Chlorpropamide (Diabinese) is a(n)? antihyperglycemic drug used as an adjunct to diet and exercise to treat A. None of the given answers is correct B. Oral /DMT2 C. Oral /DMT1 D. Oral /Diabetes insipidus E. Parenteral /DMT1 and some cases of DMT2 14. Exogenous? is associated with the release of catecholamines. A. DDP4 inhibitors B. Glucagon C. Acarbose D. Insulin E. GLP- 1 agonists

3 Endo 2 SLO Practice (online) Page 3 of Glucagon (Glucagen) is a(n)? drug used to treat A. Oral /DMT1 B. Oral/DMT2 C. Parenteral/Hyperglycemia D. Parenteral/Hypoglycemia E. Parenteral/Diabetes insipidus 16. Glucagon (Glucagen) replaces a naturally occurring hormone that acts to? A. Increase insulin sensitivity B. Reduce blood glucose levels C. Elevate blood glucose levels D. Increase glucose uptake by muscle and fat cells E. Stimulate fatty acid synthesis 17. Glyburide (Micronase) is a 2 nd generation sulfonylurea which means you must have a functioning A. Pancreas B. Gall bladder C. Kidney D. Liver E. Lung 18. Glyburide (Micronase) is a(n)? antihyperglycemic drug used as an adjunct to diet and exercise to treat A. Oral /Diabetes insipidus B. Oral /DMT2 C. Parenteral /DMT1 and some cases of DMT2 D. Oral /DMT1 E. Oral/any form of diabetes 19. Insulin and glucagon are given? to avoid total losses due to 1 st pass: A. Rectally B. Sublingually C. Parenterally D. Topically E. Transdermally 20. Insulin may cause? A. Cancer B. Hyperglycemia C. Lactic acidosis D. Pancreatitis E. Hypoglycemia 21. Lactic acidosis may be fatal in patients with poor renal function taking A. DDP4 inhibitors B. Metformin C. Sulfonylureas D. Insulin E. GLP- 1 agonists

4 Endo 2 SLO Practice (online) Page 4 of Liraglutide (Victoza) acts by? A. Blocking hepatic gluconeogenesis B. Mimicking incretins C. Stimulating the pancreas to release more insulin D. Preventing the breakdown of incretins E. Preventing the digestion and absorption of carbohydrates 23. Liraglutide (Victoza) is a(n)? antihyperglycemic drug used as an adjunct to diet and exercise to treat A. Oral /Diabetes insipidus B. Parenteral /DMT2 C. Parenteral/Diabetes insipidus D. Oral /DMT2 E. Oral /DMT1 24. Liraglutide, a?, may be associated with thyroid cancer. A. Metformin B. Sulfonylureas C. DDP4 inhibitors D. GLP- 1 agonists E. Human insulin 25. Metformin (Glucophage) is a nonsulfonylurea with a unique mechanism. It is believed to work by: A. Inhibiting an enzyme that breaks down incretins B. Preventing the digestion and absorption of carbohydrates C. Stimulating the pancreas to release insulin D. Mimicking incretins E. Blocking hepatic gluconeogenesis 26. Patients with pre- existing congestive heart failure have a higher risk of death if taking These drugs are also associated with weight gain, edema and hypoglycemia. A. Sulfonylureas B. Insulin C. GLP- 1 agonists D. PPAR gamma agonists E. Metformin 27. Pioglitazone (Actos) is a PPAR agonist used in combo with insulin or sulfonylurea to treat DMT2. It acts to? by triggering synthesis of factors involved in glucose and lipid metabolism. A. Cause insulin resistance B. It has no effect on insulin resistance C. Increase insulin resistance D. Decrease insulin resistance E. Eliminate insulin resistance 28. Pioglitazone (Actos) is a(n)? antihyperglycemic drug used as an adjunct to diet and exercise to treat? A. Oral /DMT1 B. Parenteral/hypoglycemia C. Oral /DMT2 D. Parenteral /DMT1 and some cases of DMT2 E. Oral /Diabetes insipidus

5 Endo 2 SLO Practice (online) Page 5 of Sitagliptin (Januvia) is a DPP4 inhibitor that acts to? A. Prevent the digestion and absorption of carbohydrates B. Block hepatic gluconeogenesis C. Stimulate the pancreas to release more insulin D. Prevent the breakdown of incretins E. Mimic incretins 30. Sitagliptin (Januvia) is a(n)? antihyperglycemic drug used as an adjunct to diet and exercise to treat A. Parenteral/ Hypoglycemia B. Parenteral /DMT1 and some cases of DMT2 C. Oral /DMT2 D. Oral /DMT1 E. Oral /Diabetes insipidus 31. The blood glucose lowering effects of Metformin are antagonized by A. Isoniazid or INH B. Corticosteroids, including glucocorticoids like prednisone C. Estrogens, including birth control pills D. Thiazide diuretics E. All the listed answers are correct 32. The normal effect of insulin binding is that blood glucose A. Plummets, leading to hypoglycemia B. Is maintained at one level C. Goes down D. Insulin has none of these effects E. Rises, leading to hyperglycemia 33. The severe side effects of weight gain, severe hypoglycemia and increased risk of cardiovascular death including heart attack are associated with A. GLP- 1 agonists B. Insulin C. DDP4 inhibitors D. Sulfonylureas E. Metformin 34. The type of diabetes associated with a lack of ADH is called A. Gestational diabetes B. Diabetes insipidus C. Diabetes mellitus type 2 D. Diabetes mellitus type 1 E. Cystic fibrosis diabetes 35. The type of diabetes commonly called Adult onset is related to insulin resistance and is also called A. Diabetes mellitus type 2 B. Cystic fibrosis diabetes C. Gestational diabetes D. Diabetes mellitus type 1 E. Diabetes insipidus

6 Endo 2 SLO Practice (online) Page 6 of The type of diabetes known as Juvenile onset is related to a failure of the pancreas to produce insulin and is also known as A. Diabetes mellitus type 1 B. Diabetes mellitus type 2 C. Diabetes insipidus D. Cystic fibrosis diabetes E. Gestational diabetes 37. Type of diabetes associated with pregnancy is called? A. Diabetes insipidus B. Diabetes mellitus type 1 C. Diabetes mellitus type 2 D. Cystic fibrosis diabetes E. Gestational diabetes 38. Which drug requires a functioning pancreas and so cannot be used in DMT1? A. Acarbose (Precose) B. Neutral Protamine Hagedorn insulin C. Regular (Humulin) insulin D. Metformin (Glucophage) E. Glyburide (Micronase) 39. Which drug requires functional kidneys to minimize the risk of lactic acidosis? A. Glyburide B. Metformin C. Insulin Lispro D. Chlorpropamide E. Insulin Aspart 40. Which drug requires insulin to be present, so requires either a functioning pancreas or is given as an adjunct to insulin? A. Pioglitazone (Actos) B. Liraglutide (Victoza) C. Glucagon (Glucagen) D. Insulin Lispro E. Sitagliptin (Januvia) 41. Which of the following are symptoms of HYPERglycemia? A. Lethargy, pin point pupils and respiratory depression B. Sweating, tremors and hunger C. Constipation, dry skin, tremors, dilated pupils D. Dry skin, dry mouth and thirst E. SJS, hypokalemia, kidney failure 42. Which of the following are symptoms of HYPOglycemia? A. Constipation, dry skin, tremors, dilated pupils B. Dry skin, dry mouth and thirst C. Lethargy, pin point pupils and respiratory depression D. SJS, hypokalemia, kidney failure E. Sweating, tremors and hunger

7 Endo 2 SLO Practice (online) Page 7 of Insulin is used to treat A. Only DMT1, never DMT2 B. All forms of diabetes C. Diabetes insipidus only D. Only DMT2, never DMT1 E. DMT1 and some cases of DMT2 44. Metformin (Glucophage) is a(n)? antihyperglycemic drug indicated as an adjunct to diet and exercise to treat A. Oral /DMT2 B. Parenteral /DMT1 and some cases of DMT2 C. Oral /DMT1 D. Oral /Diabetes insipidus E. Parenteral/any form of diabetes

Endocrine Pharmacology:

Endocrine Pharmacology: Endocrine Pharmacology: Part 1: Hypothalamus/Pituitary, Pineal, Thyroid/ Parathyroid, Adrenals, Ovaries/Testes Part 2: Diabetes mellitus types 1 & 2 PHRM 203 Allison Beale Types of Diabetes D. mellitus

More information

DIABETES. Mary Bruskewitz APNP, MS, BC-ADM Clinical Nurse Specialist Diabetes. November 2013

DIABETES. Mary Bruskewitz APNP, MS, BC-ADM Clinical Nurse Specialist Diabetes. November 2013 DIABETES Mary Bruskewitz APNP, MS, BC-ADM Clinical Nurse Specialist Diabetes November 2013 mbruskewitz@outlook.com Objectives Part 1 Overview of Endocrine Physiology Pathophysiology of Diabetes Diabetes

More information

I. General Considerations

I. General Considerations 1 2 3 I. General Considerations A. Type I ( Juvenile Onset or IDDM) IDDM results from autoimmune destruction of beta cells inability to secrete insulin --> ketone formation --> DKA 4 Diabetic Ketoacidosis

More information

Society for Ambulatory Anesthesia Consensus Statement on Perioperative Blood Glucose Management in Diabetic Patients Undergoing Ambulatory Surgery

Society for Ambulatory Anesthesia Consensus Statement on Perioperative Blood Glucose Management in Diabetic Patients Undergoing Ambulatory Surgery Society for Ambulatory Anesthesia Consensus Statement on Perioperative Blood Glucose Management in Diabetic Patients Undergoing Ambulatory Surgery Girish P. Joshi, MB BS, MD, FFARCSI Anesthesia & Analgesia

More information

Diabetes Oral Agents Pharmacology. University of Hawai i Hilo Pre-Nursing Program NURS 203 General Pharmacology Danita Narciso Pharm D

Diabetes Oral Agents Pharmacology. University of Hawai i Hilo Pre-Nursing Program NURS 203 General Pharmacology Danita Narciso Pharm D Diabetes Oral Agents Pharmacology University of Hawai i Hilo Pre-Nursing Program NURS 203 General Pharmacology Danita Narciso Pharm D 1 Learning Objectives Understand the role of the utilization of free

More information

Oral and Injectable Medication Options for Diabetes Treatment

Oral and Injectable Medication Options for Diabetes Treatment Oral and Injectable Medication Options for Diabetes Treatment Presented by: Dr. Daphne E. Smith, Pharm.D., CDE Clinical Assistant Professor/Clinical Pharmacist-University of Illinois at Chicago College

More information

DIABETES. overview of pharmacologic agents used in the management of. Overview 4/3/2014 OBJECTIVES. Injectable Agents

DIABETES. overview of pharmacologic agents used in the management of. Overview 4/3/2014 OBJECTIVES. Injectable Agents overview of pharmacologic agents used in the management of DIABETES Kyle Roberts, Pharm.D. PGY-1 Pharmacy Resident Saint Alphonsus RMC 1. List the different classes of diabetes medications, including the

More information

Endocrine. Hormones secreted from glands. Gonads

Endocrine. Hormones secreted from glands. Gonads Pharmacology 203 Windward Community College Endocrine Hormones secreted from glands Glands we will discuss Hypothalamus/pituitary Thyroid & Parathyroid Pancreas Adrenals Pineal Gonads Hypothalamus and

More information

RPCC Pharmacy Forum. The Type 2 Diabetes Issue. Type 2 Diabetes: The Basics

RPCC Pharmacy Forum. The Type 2 Diabetes Issue. Type 2 Diabetes: The Basics Nov/Dec 2015 Issue 11 RPCC Pharmacy Forum Special Interest Articles: Diabetes Medication Chart Insulin Chart Afreeza Did you know? Exanatide, marketed as Byetta, is the synthetic form of exendin-4, which

More information

Diabetes Mellitus. Raja Nursing Instructor. Acknowledgement: Badil 09/03/2016

Diabetes Mellitus. Raja Nursing Instructor. Acknowledgement: Badil 09/03/2016 Diabetes Mellitus Raja Nursing Instructor 09/03/2016 Acknowledgement: Badil Objective: Define Diabetes Mellitus (DM) & types of DM. Understand the pathophysiology of Type-I & II DM. List the clinical features

More information

What the Pill Looks Like. How it Works. Slows carbohydrate absorption. Reduces amount of sugar made by the liver. Increases release of insulin

What the Pill Looks Like. How it Works. Slows carbohydrate absorption. Reduces amount of sugar made by the liver. Increases release of insulin Diabetes s Oral s - Pills These are some of the pills that are currently available in Canada to treat diabetes. Each medication has benefits and side effects you should be aware of. Your diabetes team

More information

Table 1. Antihyperglycemic agents for use in type 2 diabetes

Table 1. Antihyperglycemic agents for use in type 2 diabetes Table 1. Antihyperglycemic agents for use in type 2 diabetes DRUG IN ALPHA-GLUCOSIDASE INHIBITOR: inhibits pancreatic alpha-amyle and intestinal alpha-glucoside Acarbose (Glucobay) 0.6% Negligible Not

More information

DM Fundamentals Class 4 Meds for Type 2

DM Fundamentals Class 4 Meds for Type 2 DM Fundamentals Class 4 Meds for Type 2 Beverly Thomassian, RN, MPH, BC ADM, CDE President, Diabetes Education Services Copyright 1999 2015, Diabetes Education Services, All Rights Reserved. Diabetes Meds

More information

Metformin Hydrochloride

Metformin Hydrochloride Metformin Hydrochloride 500 mg, 850 mg, 500 mg LA and 750 mg LA Tablet Description Informet is a preparation of metformin hydrochloride that belongs to a biguanide class of oral antidiabetic drugs. Metformin

More information

Objectives. How Medicine Works to Control Blood Sugar Levels. What Happens When We Eat? What is diabetes? High Blood Glucose (Hyperglycemia)

Objectives. How Medicine Works to Control Blood Sugar Levels. What Happens When We Eat? What is diabetes? High Blood Glucose (Hyperglycemia) How Medicine Works to Control Blood Sugar Levels Stacie Petersen, RN, CDE Objectives Define Diabetes List how medications work (ominous octet) Identify side effects of medications for diabetes What is

More information

FARXIGA (dapagliflozin) Jardiance (empagliflozin) tablets. Synjardy (empagliflozin and metformin hydrochloride) tablets. GLUCOPHAGE* (metformin)

FARXIGA (dapagliflozin) Jardiance (empagliflozin) tablets. Synjardy (empagliflozin and metformin hydrochloride) tablets. GLUCOPHAGE* (metformin) Type 2 Medications Drug Class How It Works Brand and Generic Names Manufacturers Usual Starting Dose The kidneys filter sugar and either absorb it back into your body for energy or remove it through your

More information

Oral and Injectable Non-insulin Antihyperglycemic Agents

Oral and Injectable Non-insulin Antihyperglycemic Agents Appendix 5: Diabetes Education and Medical Management in Adults with Diabetes Oral and Injectable Non-insulin s This directive will be implemented by RPhs, RNs or RDs who have been deemed authorized implementers.

More information

Xultophy 100/3.6. (insulin degludec, liraglutide) New Product Slideshow

Xultophy 100/3.6. (insulin degludec, liraglutide) New Product Slideshow Xultophy 100/3.6 (insulin degludec, liraglutide) New Product Slideshow Introduction Brand name: Xultophy Generic name: Insulin degludec, liraglutide Pharmacological class: Human insulin analog + glucagon-like

More information

DM Fundamentals Class 4 Meds for Type 2

DM Fundamentals Class 4 Meds for Type 2 DM Fundamentals Class 4 Meds for Type 2 Beverly Thomassian, RN, MPH, BC ADM, CDE President, Diabetes Education Services Copyright 1999 2015, Diabetes Education Services, All Rights Reserved. Diabetes Meds

More information

Normal Fuel Metabolism Five phases of fuel homeostasis have been described A. Phase I is the fed state (0 to 3.9 hours after meal/food consumption),

Normal Fuel Metabolism Five phases of fuel homeostasis have been described A. Phase I is the fed state (0 to 3.9 hours after meal/food consumption), Normal Fuel Metabolism Five phases of fuel homeostasis have been described A. Phase I is the fed state (0 to 3.9 hours after meal/food consumption), in which blood glucose predominantly originates from

More information

Wayne Gravois, MD August 6, 2017

Wayne Gravois, MD August 6, 2017 Wayne Gravois, MD August 6, 2017 Americans with Diabetes (Millions) 40 30 Source: National Diabetes Statistics Report, 2011, 2017 Millions 20 10 0 1980 2009 2015 2007 - $174 Billion 2015 - $245 Billion

More information

Diabetes Management: A diagnostic perspective

Diabetes Management: A diagnostic perspective Diabetes Management: A diagnostic perspective Images: http://www.engadget.com/2009/09/23/bayer-introduces-countour-usb-glucose-meter/ http://www.medtronicdiabetes.com/treatment-and-products/minimed-530g-diabetes-system-with-enlite

More information

Drugs used in Diabetes. Dr Andrew Smith

Drugs used in Diabetes. Dr Andrew Smith Drugs used in Diabetes Dr Andrew Smith Plan Introduction Insulin Sensitising Drugs: Metformin Glitazones Insulin Secretagogues: Sulphonylureas Meglitinides Others: Acarbose Incretins Amylin Analogues Damaglifozin

More information

Antihyperglycemic Agents in Diabetes. Jamie Messenger, PharmD, CPP Department of Family Medicine East Carolina University August 18, 2014

Antihyperglycemic Agents in Diabetes. Jamie Messenger, PharmD, CPP Department of Family Medicine East Carolina University August 18, 2014 Antihyperglycemic Agents in Diabetes Jamie Messenger, PharmD, CPP Department of Family Medicine East Carolina University August 18, 2014 Objectives Review 2014 ADA Standards of Medical Care in DM as they

More information

YOU HAVE DIABETES. Angie O Connor Community Diabetes Nurse Specialist 25th September 2013

YOU HAVE DIABETES. Angie O Connor Community Diabetes Nurse Specialist 25th September 2013 YOU HAVE DIABETES Angie O Connor Community Diabetes Nurse Specialist 25th September 2013 Predicated 2015 figures are already met 1 in 20 have diabetes:1in8 over 60years old Definite Diagnosis is key Early

More information

Diabetes Mellitus II CPG

Diabetes Mellitus II CPG 1 Diabetes Mellitus II CPG Candidates for Screening Integrated Complex Care Patients: Check Yearly Prediabetes: Check Yearly No Diabetes Mellitus (DM) Risk Factors: Check at Age 45, Repeat Every 3 Years

More information

What s New in Diabetes Treatment. Disclosures

What s New in Diabetes Treatment. Disclosures What s New in Diabetes Treatment Shiri Levy M.D. Henry Ford Hospital Senior Staff Physician Service Chief, West Bloomfield Hospital Endocrinology, Metabolism, Bone and Mineral Disorders Disclosures None

More information

The Community Pharmacist s Role in Diabetes Treatment

The Community Pharmacist s Role in Diabetes Treatment CONTINUING EDUCATION The Community Pharmacist s Role in Diabetes Treatment By Kimberly Ference, PharmD U pon completion of this activity, the pharmacist should be able to achieve these directives: 1. Describe

More information

Jonathan Stoehr, MD PhD Endocrinology, Diabetes, Metabolism and Nutrition Virginia Mason Medical Center Seattle, WA 2012 Virginia Mason Medical

Jonathan Stoehr, MD PhD Endocrinology, Diabetes, Metabolism and Nutrition Virginia Mason Medical Center Seattle, WA 2012 Virginia Mason Medical Jonathan Stoehr, MD PhD Endocrinology, Diabetes, Metabolism and Nutrition Virginia Mason Medical Center Seattle, WA There is no conflict of interest that could be perceived as prejudicing the impartiality

More information

Diabetes Medication Updates Erica Bukovich, PharmD, BC-ADM, CDE September 20, 2018

Diabetes Medication Updates Erica Bukovich, PharmD, BC-ADM, CDE September 20, 2018 Diabetes Medication Updates Erica Bukovich, PharmD, BC-ADM, CDE September 20, 2018 Learning Objectives Identify medication classes available for treatment of individuals with diabetes. Demonstrate understanding

More information

Diabetes Medications: Oral Anti-Hyperglycemic Medications

Diabetes Medications: Oral Anti-Hyperglycemic Medications Diabetes Medications: Oral Anti-Hyperglycemic Medications Medication Types 1. Biguanides 2. Sulfonylureas 3. Thiazolidinediones (TZDs) 4. Alpha-Glucosidase Inhibitors 5. D-Phenylalanine Meglitinides 6.

More information

Oral Medication for the Management of Diabetes Mechanism of. Duration of Daily Dosing Action

Oral Medication for the Management of Diabetes Mechanism of. Duration of Daily Dosing Action Glyburide (Micronase, Diabeta, Glynase) Glipizide (Glucotrol) Glipizide XL (Glucotrol XL) Glimepiride (Amaryl) Prandin (Repaglinide) Starlix (Nateglinide) 1.25, 2.5, 5mg tabs, Dosing: 2.5-20 mg 12- (Glynase:

More information

Newer and Expensive treatment of diabetes. Endocrinology Visiting Associate Professor Institute of Medicine TUTH

Newer and Expensive treatment of diabetes. Endocrinology Visiting Associate Professor Institute of Medicine TUTH Newer and Expensive treatment of diabetes Jyoti Bhattarai MD Endocrinology Visiting Associate Professor Institute of Medicine TUTH Four out of every five people with diabetes now live in developing countries.

More information

Type 2 Diabetes: Where Do We Start with Treatment? DIABETES EDUCATION. Diabetes Mellitus: Complications and Co-Morbid Conditions

Type 2 Diabetes: Where Do We Start with Treatment? DIABETES EDUCATION. Diabetes Mellitus: Complications and Co-Morbid Conditions Diabetes Mellitus: Complications and Co-Morbid Conditions ADA Guidelines for Glycemic Control: 2016 Retinopathy Between 2005-2008, 28.5% of patients with diabetes 40 years and older diagnosed with diabetic

More information

Type II Diabetes Improving Blood Sugar Control. Geneva Clark Briggs, Pharm.D., BCPS

Type II Diabetes Improving Blood Sugar Control. Geneva Clark Briggs, Pharm.D., BCPS Type II Diabetes Improving Blood Sugar Control Geneva Clark Briggs, Pharm.D., BCPS Overview Importance of glucose control State of control Review available therapies Helping patients achieve control The

More information

Abbreviations DPP-IV dipeptidyl peptidase IV DREAM Diabetes REduction Assessment with ramipril and rosiglitazone

Abbreviations DPP-IV dipeptidyl peptidase IV DREAM Diabetes REduction Assessment with ramipril and rosiglitazone Index Abbreviations DPP-IV dipeptidyl peptidase IV DREAM Diabetes REduction Assessment with ramipril and rosiglitazone Medication GAD glutamic acid decarboxylase GLP-1 glucagon-like peptide 1 NPH neutral

More information

Joslin Diabetes Center Joslin Diabetes Forum 2013: The Impact of Comorbidities on Glucose Control Scenario 2: Reduced Renal Function

Joslin Diabetes Center Joslin Diabetes Forum 2013: The Impact of Comorbidities on Glucose Control Scenario 2: Reduced Renal Function Scenario 2: Reduced Renal Function 62 y.o. white man with type 2 diabetes for 18 years Hypertension and hypercholesterolemia Known proliferative retinopathy Current medications: Metformin 1000 mg bid Glyburide

More information

INSULIN OVERVIEW. Type Brand Name Onset Peak Duration Role in glucose management Page Rapid-Acting lispro min. 3-5 hrs min.

INSULIN OVERVIEW. Type Brand Name Onset Peak Duration Role in glucose management Page Rapid-Acting lispro min. 3-5 hrs min. INSULIN OVERVIEW Type Brand Name Onset Peak Duration Role in glucose management Page Rapid-Acting lispro Humalog 15-30 min 30-90 min 3-5 hrs aspart glulisine Short-Acting Regular insulin NovoLog Apidra

More information

In-Hospital Management of Diabetes. Dr Benjamin Schiff Assistant Professor McGill University

In-Hospital Management of Diabetes. Dr Benjamin Schiff Assistant Professor McGill University In-Hospital Management of Diabetes Dr Benjamin Schiff Assistant Professor McGill University No conflict of interest to declare CLINICAL SCENARIO 62 y/o male with hx of DM 2, COPD, and HT is admitted with

More information

4/9/2018 HOW TO REGULATE DIABETES MEDICATIONS. By Sarah Froemsdorf MSN, RNC, CDE, FNP DISCLOSURES NONE. Diagnosis

4/9/2018 HOW TO REGULATE DIABETES MEDICATIONS. By Sarah Froemsdorf MSN, RNC, CDE, FNP DISCLOSURES NONE. Diagnosis HOW TO REGULATE DIABETES MEDICATIONS By Sarah Froemsdorf MSN, RNC, CDE, FNP DISCLOSURES NONE Diagnosis 1 NORMAL BODY The normal pancreas releases one unit of insulin every hour all day. The normal pancreas

More information

Pancreas Fox Chapter 18 part 2 (also Chapter 19.3 & 19.4)

Pancreas Fox Chapter 18 part 2 (also Chapter 19.3 & 19.4) Vert Phys PCB3743 Pancreas Fox Chapter 18 part 2 (also Chapter 19.3 & 19.4) T. Houpt, Ph.D. Anatomy of Digestive System Peristalsis Stomach and Acid Secretion Liver and Bile Secretion Pancreas and pancreatic

More information

Glucose Control drug treatments

Glucose Control drug treatments Glucose Control drug treatments It should be noted that glitazones are under suspicion of precipitating acute cardiac events and current recommendations contraindicate the use of glitazones in patients

More information

TABLE 1A : Formulary Coverage of Insulin Therapies & Indications for Use in Various Populations

TABLE 1A : Formulary Coverage of Insulin Therapies & Indications for Use in Various Populations 177 TABLE 1A : Formulary Coverage of Insulin Therapies & Indications for Use in Various Populations Formulary Coverage Indication for use with: INSULIN THERAPY NS NB NL PE ADULTS PEDIATRICS PREGNANCY BOLUS

More information

What s New in Diabetes Medications. Jena Torpin, PharmD

What s New in Diabetes Medications. Jena Torpin, PharmD What s New in Diabetes Medications Jena Torpin, PharmD 1 Objectives Discuss new medications in the management of diabetes Understand the mechanism of the medications discussed Understand the side effects

More information

Hot Topics: The Future of Diabetes Management Cutting Edge Medication and Technology-Based Care

Hot Topics: The Future of Diabetes Management Cutting Edge Medication and Technology-Based Care Hot Topics: The Future of Diabetes Management Cutting Edge Medication and Technology-Based Care Mary Jean Christian, MA, MBA, RD, CDE Diabetes Program Coordinator UC Irvine Health Hot Topics: Diabetes

More information

How to Fight Diabetes and Win. Diabetes. Medications

How to Fight Diabetes and Win. Diabetes. Medications How to Fight Diabetes and Win Diabetes Medications MEDICATIONS FOR DIABETES According to the American Diabetes Association, 85% of adults diagnosed with diabetes take insulin and/or oral medication to

More information

What is Diabetes Mellitus?

What is Diabetes Mellitus? Normal Glucose Metabolism What is Diabetes Mellitus? When the amount of glucose in the blood increases, After a meal, it triggers the release of the hormone insulin from the pancreas. Insulin stimulates

More information

TABLE 1A: Formulary Coverage of Insulin Therapies & Indications for Use in Various Populations

TABLE 1A: Formulary Coverage of Insulin Therapies & Indications for Use in Various Populations 177 TABLE 1A: Formulary Coverage of Insulin Therapies & Indications for Use in Various Populations TABLE 1A : Formulary Coverage of Insulin Therapies & Indications for Use in Various Populations Formulary

More information

Antidiabetic Agents CHAPTER BIGUANIDES

Antidiabetic Agents CHAPTER BIGUANIDES ajt/shutterstock, Inc. CHAPTER 2 Antidiabetic Agents Charles Ruchalski, PharmD, BCPS BIGUANIDES For newly diagnosed patients with type 2 diabetes, the biguanide metformin is the drug of choice for initial

More information

AACE/ACE Consensus Statement American Association of Clinical Endocrinologists and American College of Endocrinology

AACE/ACE Consensus Statement American Association of Clinical Endocrinologists and American College of Endocrinology AACE/ACE Consensus Statement 2017 American Association of Clinical Endocrinologists and American College of Endocrinology Jeff Worrell, Lt Col, USAF (retired) CRNA MSN Why am I here? Metabolic Syndrome

More information

Newer Drugs in the Management of Type 2 Diabetes Mellitus

Newer Drugs in the Management of Type 2 Diabetes Mellitus Newer Drugs in the Management of Type 2 Diabetes Mellitus Dr. C. Dinesh M. Naidu Professor of Pharmacology, Kamineni Institute of Medical Sciences, Narketpally. 1 Presentation Outline Introduction Pathogenesis

More information

3/8/2011. Julie M. Sease, Pharm D, BCPS, CDE Associate Professor of Pharmacy Practice Presbyterian College School of Pharmacy

3/8/2011. Julie M. Sease, Pharm D, BCPS, CDE Associate Professor of Pharmacy Practice Presbyterian College School of Pharmacy Summarize revisions to the 2011 American Diabetes Association clinical practice guidelines. Evaluate bromocriptine as a therapeutic option in the management of type 2 diabetes. Compare and contrast the

More information

History of Investigation

History of Investigation Acini - Pancreatic juice (1º) (2º) Secretions- neuronal and hormonal mechanisms 1) Secretin - bicarbonate rich 2) Cholecystokinin - enzyme rich Islets of Langerhans (contain 4 cell types) Alpha cells (α)-

More information

The Many Faces of T2DM in Long-term Care Facilities

The Many Faces of T2DM in Long-term Care Facilities The Many Faces of T2DM in Long-term Care Facilities Question #1 Which of the following is a risk factor for increased hypoglycemia in older patients that may suggest the need to relax hyperglycemia treatment

More information

Pancreatic b-cell Dysfunction in Type 2 Diabetes ZIAD KAHWASH, M.D. Insulin resistance: Defects in Insulin Signaling

Pancreatic b-cell Dysfunction in Type 2 Diabetes ZIAD KAHWASH, M.D. Insulin resistance: Defects in Insulin Signaling Plasma insulin (mu/ml) ZIAD KAHWASH, M.D. resistance: Defects in Signaling Increased glucose production Glucose Insufficient glucose disposal X Liver glucagon insulin Pancreas Peripheral tissues (skeletal

More information

Quick Guide MEDICATIONS 7th Edition Evan Sisson, Pharm.D., MHA, CDE

Quick Guide MEDICATIONS 7th Edition Evan Sisson, Pharm.D., MHA, CDE Quick Guide to MEDICATIONS 7th Edition Evan Sisson, Pharm.D., MHA, CDE Adapted from The Art and Science of Diabetes Self-Management Education Desk Reference 2017, American Association of Diabetes Educators,

More information

The information in this guide comes from a government-funded review of research about pills for type 2 diabetes.

The information in this guide comes from a government-funded review of research about pills for type 2 diabetes. effectivehealthcare.ahrq.gov Pills for Type 2 Diabetes: A Guide for Adults Consumer Summary Guide published 5 Dec 2007 1. Introduction What does this guide cover? Type 2 diabetes means the body has a problem

More information

第十五章. Diabetes Mellitus

第十五章. Diabetes Mellitus Diabetes-1/9 第十五章 Diabetes Mellitus 陳曉蓮醫師 2/9 - Diabetes 羅東博愛醫院 Management of Diabetes mellitus A. DEFINITION OF DIABETES MELLITUS Diabetes Mellitus is characterized by chronic hyperglycemia with disturbances

More information

Treatment Options for Diabetes: An Update

Treatment Options for Diabetes: An Update Treatment Options for Diabetes: An Update A/Prof. Marg McGill Manager, Diabetes Centre Dr. Ted Wu Staff Specialist Endocrinologist Diabetes Centre Centre of Health Professional Education Education Provider

More information

Soliqua 100/33. (insulin glargine, lixisenatide) New Product Slideshow

Soliqua 100/33. (insulin glargine, lixisenatide) New Product Slideshow Soliqua 100/33 (insulin glargine, lixisenatide) New Product Slideshow Introduction Brand name: Soliqua 100/33 Generic name: Insulin glargine (rdna origin), lixisenatide Pharmacological class: Human insulin

More information

Endocrine System. Regulating Blood Sugar. Thursday, December 14, 17

Endocrine System. Regulating Blood Sugar. Thursday, December 14, 17 Endocrine System Regulating Blood Sugar Stress results in nervous and hormonal responses. The adrenal glands are located above each kidney. Involved in stress response. Stress Upsets Homeostasis Stress

More information

Images have been removed from the PowerPoint slides in this handout due to copyright restrictions. Insulins. Rapid Short Intermediate Long Mix

Images have been removed from the PowerPoint slides in this handout due to copyright restrictions. Insulins. Rapid Short Intermediate Long Mix Diabetes Medications Diabetes Medications Type 1 Insulin is needed Type 2 Oral Diabetes Medications Or Oral Diabetes Medications plus Insulin Or Insulin Alone Diabetes Medications Secretagogues Glipizide

More information

Age-adjusted Percentage of U.S. Adults Who Were Obese or Who Had Diagnosed Diabetes

Age-adjusted Percentage of U.S. Adults Who Were Obese or Who Had Diagnosed Diabetes Age-adjusted Percentage of U.S. Adults Who Were Obese or Who Had Diagnosed Diabetes Obesity (BMI 30 kg/m 2 ) 1994 2000 2009 No Data 26.0% Diabetes 1994 2000 2009

More information

Clinical Cases in Diabetes Management. Joseph Cook D.O.

Clinical Cases in Diabetes Management. Joseph Cook D.O. Clinical Cases in Diabetes Management Joseph Cook D.O. Objectives State the prevalence of Diabetes Mellitus in Ohio State the percentage of diabetic patients in the U.S. treated by Primary Care Physicians

More information

Therapy of Diabetes Mellitus

Therapy of Diabetes Mellitus 2016 edition by Jayne S. Reuben, PhD Department of Biomedical Sciences University of South Carolina School of Medicine Greenville Originally developed by Elliott Chideckel, MD Department of Medicine Robert

More information

Pharmacology Updates. Quang T Nguyen, FACP, FACE, FTOS 11/18/17

Pharmacology Updates. Quang T Nguyen, FACP, FACE, FTOS 11/18/17 Pharmacology Updates Quang T Nguyen, FACP, FACE, FTOS 11/18/17 14 Classes of Drugs Available for the Treatment of Type 2 DM in the USA ### Class A1c Reduction Hypoglycemia Weight Change Dosing (times/day)

More information

Diabetes Basics. Type 1 diabetes The body cannot make insulin Requires insulin injection Is not treated with oral diabetes medicines (pills)

Diabetes Basics. Type 1 diabetes The body cannot make insulin Requires insulin injection Is not treated with oral diabetes medicines (pills) Diabetes Basics What is Diabetes? Diabetes is a disease in which the pancreas is unable to make insulin or the body is unable to use insulin or both. This leads to high blood sugar levels in the blood.

More information

Non-Insulin Diabetes Medications Summary

Non-Insulin Diabetes Medications Summary Non-Insulin Diabetes Medications Summary Medications marked with an asterisk (*) can cause hypoglycemia INSULIN SECRETAGOGUES Sulfonylureas* GLYBURIDE* (Diabeta) (Micronase) production. Side effects: Potential

More information

Rhonda Eustice, PharmD, CDE. Will Power lasts about two weeks and is soluble in alcohol. Mark Twain

Rhonda Eustice, PharmD, CDE. Will Power lasts about two weeks and is soluble in alcohol. Mark Twain Rhonda Eustice, PharmD, CDE Will Power lasts about two weeks and is soluble in alcohol. Mark Twain Diabetes Management: The Three Legged Stool Diet Medication Exercise Objectives Know the treatment goals

More information

Glyceamic control is indicated by 1. Fasting blood sugar less than 126 mg/dl 2. Random blood sugar 3. HbA1c less than 6.5 % Good glycaemic control

Glyceamic control is indicated by 1. Fasting blood sugar less than 126 mg/dl 2. Random blood sugar 3. HbA1c less than 6.5 % Good glycaemic control Glyceamic control is indicated by 1. Fasting blood sugar less than 126 mg/dl 2. Random blood sugar 3. HbA1c less than 6.5 % Good glycaemic control can prevent many of early type 1 DM(in DCCT trail ). UK

More information

Diabesity. Metabolic dysfunction that ranges from mild blood glucose imbalance to full fledged Type 2 DM Signs

Diabesity. Metabolic dysfunction that ranges from mild blood glucose imbalance to full fledged Type 2 DM Signs Diabesity Metabolic dysfunction that ranges from mild blood glucose imbalance to full fledged Type 2 DM Signs Abdominal obesity Low HDL, high LDL, and high triglycerides HTN High blood glucose (F>100l,

More information

New Treatments for Type 2 diabetes. Nandini Seevaratnam April 2016 Rushcliffe Patient Forum

New Treatments for Type 2 diabetes. Nandini Seevaratnam April 2016 Rushcliffe Patient Forum New Treatments for Type 2 diabetes Nandini Seevaratnam April 2016 Rushcliffe Patient Forum Overview Growing population of Type 2 diabetes Basic science on what goes wrong Current treatments Why there is

More information

Diabetes in Pregnancy

Diabetes in Pregnancy Diabetes in Pregnancy Ebony Boyce Carter, MD, MPH Division of Maternal Fetal Medicine Washington University School of Medicine Disclosures I have no financial disclosures to report. Objectives Review the

More information

Update on Diabetes Mellitus

Update on Diabetes Mellitus Update on Diabetes Mellitus Treatment: Targeting the Incretin System Overview Underlying defects with Type 2 diabetes Importance of managing postprandial glucose control Amylin Incretin Hormones New therapies

More information

DIABETES RESEARCH A CLINICIAN S OVERVIEW

DIABETES RESEARCH A CLINICIAN S OVERVIEW DIABETES RESEARCH 2012- A CLINICIAN S OVERVIEW Alan B. Cortez, MD Chief, Pediatrics Pediatric Endocrinology Kaiser-Permanente Orange County January 21, 2012 Research Overview Biotechnology Treatment Pharmaceutical

More information

Objectives. Recognize all available medical treatment options for diabetes. Individualize treatment and glycemic target based on patient factors

Objectives. Recognize all available medical treatment options for diabetes. Individualize treatment and glycemic target based on patient factors No disclosure Objectives Recognize all available medical treatment options for diabetes Individualize treatment and glycemic target based on patient factors Should be able to switch to more affordable

More information

Choosing a Diabetes Strategy Where to Start and Where to Go

Choosing a Diabetes Strategy Where to Start and Where to Go Choosing a Diabetes Strategy Where to Start and Where to Go Erin Keely, MD, FRCPC; and Sharon Brez, RN, BScN, MA(Ed), CDE As presented at the University of Ottawa's 52nd Annual Refresher Course for Family

More information

Diabetes Mellitus Type 2

Diabetes Mellitus Type 2 Diabetes Mellitus Type 2 What is it? Diabetes is a common health problem in the U.S. and the world. In diabetes, the body does not use the food it digests well. It is hard for the body to use carbohydrates

More information

Diabetes School October 2016

Diabetes School October 2016 Diabetes School October 2016 Name Change- Why? Shorter Has my name in it Emphasizes a major part of the practice Still see non-research patients Novo Nordisk Lilly sanofi aventis! Thank You to our LucasResearch

More information

Initiating Injectable Therapy in Type 2 Diabetes

Initiating Injectable Therapy in Type 2 Diabetes Initiating Injectable Therapy in Type 2 Diabetes David Doriguzzi, PA C Learning Objectives To understand current Diabetes treatment guidelines To understand how injectable medications fit into current

More information

Management of Type 2 Diabetes. Why Do We Bother to Achieve Good Control in DM2. Insulin Secretion. The Importance of BP and Glucose Control

Management of Type 2 Diabetes. Why Do We Bother to Achieve Good Control in DM2. Insulin Secretion. The Importance of BP and Glucose Control Insulin Secretion Management of Type 2 Diabetes DG van Zyl Why Do We Bother to Achieve Good Control in DM2 % reduction 0-5 -10-15 -20-25 -30-35 -40 The Importance of BP and Glucose Control Effects of tight

More information

Mae Sheikh-Ali, M.D. Assistant Professor of Medicine Division of Endocrinology University of Florida College of Medicine- Jacksonville

Mae Sheikh-Ali, M.D. Assistant Professor of Medicine Division of Endocrinology University of Florida College of Medicine- Jacksonville Mae Sheikh-Ali, M.D. Assistant Professor of Medicine Division of Endocrinology University of Florida College of Medicine- Jacksonville Pathogenesis of Diabetes Mellitus (DM) Criteria for the diagnosis

More information

TREATMENT OF DIABETES AFTER METFORMIN GREGG GERETY, MD ALBANY MEDICAL COLLEGE, DIVISION OF COMMUNITY ENDOCRINOLOGY JULY 14, 2017

TREATMENT OF DIABETES AFTER METFORMIN GREGG GERETY, MD ALBANY MEDICAL COLLEGE, DIVISION OF COMMUNITY ENDOCRINOLOGY JULY 14, 2017 TREATMENT OF DIABETES AFTER METFORMIN GREGG GERETY, MD ALBANY MEDICAL COLLEGE, DIVISION OF COMMUNITY ENDOCRINOLOGY JULY 14, 2017 Outline Review treatment algorithms from ADA/ EASD & ACE/AACE. Review positive

More information

Comprehensive Diabetes Treatment

Comprehensive Diabetes Treatment Comprehensive Diabetes Treatment Joshua L. Cohen, M.D., F.A.C.P. Professor of Medicine Interim Director, Division of Endocrinology & Metabolism The George Washington University School of Medicine Diabetes

More information

Diabetes, Drugs and Dangerous Discrepancies. Sally Bodenhamer, OD, OT/L, CDE

Diabetes, Drugs and Dangerous Discrepancies. Sally Bodenhamer, OD, OT/L, CDE Diabetes, Drugs and Dangerous Discrepancies Sally Bodenhamer, OD, OT/L, CDE I have no disclosures Disclosures $245 BILLION American DM ASSOC 2012 cost of Diabetes Economic Costs of Diabetes in the U.S.

More information

Reviewing Diabetes Guidelines. Newsletter compiled by Danny Jaek, Pharm.D. Candidate

Reviewing Diabetes Guidelines. Newsletter compiled by Danny Jaek, Pharm.D. Candidate Reviewing Diabetes Guidelines Newsletter compiled by Danny Jaek, Pharm.D. Candidate AL AS KA N AT IV E DI AB ET ES TE A M Volume 6, Issue 1 Spring 2011 Dia bet es Dis pat ch There are nearly 24 million

More information

FUNDING: MICIS mandated by Maine Legislature, funded by fees collected from pharmaceutical companies as a cost of doing business in the state.

FUNDING: MICIS mandated by Maine Legislature, funded by fees collected from pharmaceutical companies as a cost of doing business in the state. GOAL: To improve clinical outcomes by delivering upto-date, evidence-based prescribing information, using data and guidelines developed by noncommercial sources FUNDING: MICIS mandated by Maine Legislature,

More information

Blood Glucose Monitoring

Blood Glucose Monitoring Blood Glucose Monitoring What is Glucose? A simple sugar that enters the diet as part of sucrose, lactose, or maltose Part of a polysaccharide called dietary starch Most of the body s energy comes from

More information

associated with serious complications, but reduce occurrences with preventive measures

associated with serious complications, but reduce occurrences with preventive measures Wk 9. Management of Clients with Diabetes Mellitus 1. Diabetes Mellitus body s inability to metabolize carbohydrates, fats, proteins hyperglycemia associated with serious complications, but reduce occurrences

More information

Clinical Practice Guidelines

Clinical Practice Guidelines Clinical Practice Guidelines Diabetes Objective The purpose is to guide the appropriate diagnosis and management of Diabetes. This guideline is designed to assist the clinician by providing a framework

More information

6/1/2018. Lou Haenel, IV, DO, FACE, FACOI Endocrinology Roper St Francis Charleston, SC THE OMINOUS OCTET: HOW PATHOPHYSIOLOGY AND THERAPY MERGE

6/1/2018. Lou Haenel, IV, DO, FACE, FACOI Endocrinology Roper St Francis Charleston, SC THE OMINOUS OCTET: HOW PATHOPHYSIOLOGY AND THERAPY MERGE Lou Haenel, IV, DO, FACE, FACOI Endocrinology Roper St Francis Charleston, SC THE OMINOUS OCTET: HOW PATHOPHYSIOLOGY AND THERAPY MERGE 1 2 3 Sulfonylureas Glipizide Glyburide Glimeperide 4 Metformin Gold

More information

Disclosure. Learning Objectives. Case. Diabetes Update: Incretin Agents in Diabetes-When to Use Them? I have no disclosures to declare

Disclosure. Learning Objectives. Case. Diabetes Update: Incretin Agents in Diabetes-When to Use Them? I have no disclosures to declare Disclosure Diabetes Update: Incretin Agents in Diabetes-When to Use Them? I have no disclosures to declare Spring Therapeutics Update 2011 CSHP BC Branch Anar Dossa BScPharm Pharm D CDE April 20, 2011

More information

Type 2 Diabetes Mellitus 2011

Type 2 Diabetes Mellitus 2011 2011 Michael T. McDermott MD Director, Endocrinology and Diabetes Practice University of Colorado Hospital Michael.mcdermott@ucdenver.edu Diabetes Mellitus Diagnosis 2011 Diabetes Mellitus Fasting Glucose

More information

What s New on the Horizon: Diabetes Medication Update

What s New on the Horizon: Diabetes Medication Update What s New on the Horizon: Diabetes Medication Update Outline of Talk Newly released and upcoming medications: the incretins, DPP-IV inhibitors, and what s coming Revised ADA/EASD and AACE guidelines:

More information

Julie White, MS Administrative Director Boston University School of Medicine Continuing Medical Education

Julie White, MS Administrative Director Boston University School of Medicine Continuing Medical Education MENTOR QI Diabetes Performance Improvement Initiative, Getting Patients to Goal in Glycemic Control: Current Data Julie White, MS Administrative Director Boston University School of Medicine Continuing

More information

2018 Diabetes Summit Managing Diabetes: An Art and a Science

2018 Diabetes Summit Managing Diabetes: An Art and a Science 2018 Diabetes Summit Managing Diabetes: An Art and a Science Natasha Petry, PharmD, BCACP NDSU College of Health Professions, School of Pharmacy, Department of Pharmacy Practice Patient-Centered Medical

More information

Care of patients with endocrine system disorders

Care of patients with endocrine system disorders King Saud University College of Nursing Medical Surgical Department Application of Adult Health Nursing Skills ( NUR 317 ) Care of patients with endocrine system disorders Prepared by Mrs: Alwah M. Alkathiri

More information

What s New on the Horizon: Diabetes Medication Update. Michael Shannon, MD Providence Endocrinology, Olympia WA

What s New on the Horizon: Diabetes Medication Update. Michael Shannon, MD Providence Endocrinology, Olympia WA What s New on the Horizon: Diabetes Medication Update Michael Shannon, MD Providence Endocrinology, Olympia WA 1 Outline of Talk Newly released and upcoming medications: the incretins, DPP-IV inhibitors,

More information

Oral Hypoglycemics and Risk of Adverse Cardiac Events: A Summary of the Controversy

Oral Hypoglycemics and Risk of Adverse Cardiac Events: A Summary of the Controversy Oral Hypoglycemics and Risk of Adverse Cardiac Events: A Summary of the Controversy Jeffrey Boord, MD, MPH Advances in Cardiovascular Medicine Kingston, Jamaica December 7, 2012 VanderbiltHeart.com Outline

More information

Type. Diabetes Drugs. A Review

Type. Diabetes Drugs. A Review Type Diabetes is a common diagnosis for home care patients. Diabetes drugs are now available that target the multiple defects of metabolism that characterize Type 2 diabetes. Understanding the wide variety

More information